Crenolanib (CP-868596) - 98%, high purity , Tyrosine-protein kinase receptor FLT3 inhibitor, CAS No.670220-88-9, Tyrosine-protein kinase receptor FLT3 inhibitor

Item Number

C127776

• Synonyms: Crenolanib | 670220-88-9 | Crenolanib (CP-868596) | CP-868596 | ARO-002 | Crenolanib [USAN] | CP-868,596 | ARO 002 | CP 868596 | CP-868596 (Crenolanib) | 1-(2-(5-((3-Methyloxetan-3-yl)methoxy)-1H-benzo-[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine | LQF7I567TQ | CP868569 | Cren
• Specifications & Purity: Moligand™, ≥98%
• Biochemical and Physiological Mechanisms: Potent inhibitor of PDGFR (Kd for alpha = 2.1 nM; beta = 3.2 nM) and FLT3 (Kd = 0.74 nM). Type I inhibitor that binds only the active kinase conformation. Active towards imatinib-resistance assciated PDGFR-alpha mutations (D842I, D842V, D842Y, DI842-843M
• Storage Temp: Store at -20°C
• Shipped In: Ice chest + Ice pads
• Grade: Moligand™
• Action Type: INHIBITOR
• Mechanism of action: Tyrosine-protein kinase receptor FLT3 inhibitor
• Note: Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Refer to SDS for further information Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

Product Description

Crenolanib (CP-868596, ARO 002) is a potent and selective PDGFRα/β inhibitor with a Kd of 2.1 nM/3.2 nM in CHO cells. It can also effectively inhibit FLT3. It is sensitive to the D842V mutant and sensitive to the V561D mutant. It is not sensitive, and the selectivity for PDGFR is more than 100 times higher than that for c-Kit, VEGFR-2, TIE-2, FGFR-2, EGFR, erbB2, and Src. Crenolanib can help induce mitochondrial autophagy.